InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-3.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Nibauer Lisa, Président et Responsable de l'Unité d'Affaires - Diagnostics. Officer active across 2 companies, notably ORASURE TECHNOLOGIES INC. Aggregated, 7 filings have been recorded. Activity tracked since 11 May 2021. The latest transaction was filed on 11 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
1,606 shares@ US$5.0550.0037% mcap1.6% of flowCommon StockSEC:0001062993-22-012238:0
2,606 shares@ US$8.860.0100% mcap4.1% of flowCommon StockSEC:0001593968-22-000404:0
2,606 shares@ US$8.860.0100% mcap4.4% of flowCommon StockSEC:0001593968-22-000404
60,901 shares@ US$8.210.21% mcap95.6% of flowCommon StockSEC:0001593968-22-000179
60,901 shares@ US$8.210.21% mcap89.2% of flowCommon StockSEC:0001593968-22-000179:0
1,606 shares@ US$9.550.0061% mcap2.5% of flowCommon StockSEC:0001593968-21-001313:0
1,606 shares@ US$9.552.5% of flowCommon StockSEC:0001593968-21-001313
7 of 7 declarations
About Nibauer Lisa
Lisa Nibauer is the President of the Diagnostics Business Unit at ORASURE TECHNOLOGIES INC. She is responsible for the strategic direction of this unit, contributing to the innovation and growth of the company. Her expertise is essential in addressing market needs.
